Immunoadsorption columns sales will expand through 2036, with cardiology holding an 18.0% share in 2026 as the leading indication segment. The market was valued at USD 131.00 million in 2025 and is expected to reach USD 344.92 million by 2036, creating an incremental opportunity of USD 201.87 million.